01—Abstract
Summary
Summary of the 8-K filed May 12, 2025. Cited figures are marked; the original filing is the authoritative source.
On May 12, 2025, 3M agreed to a proposed Judicial Consent Order with the State of New Jersey resolving legacy PFAS claims tied to the Chambers Works site in Salem County (currently owned by Chemours, formerly DuPont) and extending to statewide PFAS-related claims the State has or may have against 3M in the future.
The settlement is subject to a public notice and comment period and court approval, and 3M admits no liability. Settlement payments are scheduled over roughly 24 years, with total Settlement Payments of $400 million to $450 milliona, subject to credits and adjustments, including a New Jersey Leadership Payment of $50 million to $100 million. For investors, the financial impact is modest relative to 3M's scale.
3M expects a pre-tax charge of approximately $285 millionb in Q2 2025, comprising about $210 million for the Chambers Works resolution and other settlement elements (present value of payments beginning in 2026 over eight years) and about $75 million for existing and future statewide PFAS claims (present value of payments from 2030 through 2050). 3M intends to treat the charge as an adjustment to non-GAAP results, so GAAP earnings will reflect it while adjusted results will not. The agreement is strategically significant because it removes a major overhang on a large, state-level PFAS exposure and gives 3M finality on statewide claims without further litigation, while reinforcing its previously announced exit from PFAS manufacturing by the end of 2025.
Key uncertainties remain: the final amount depends partly on 3M's obligations under the 2023 public water supplier class settlement, potential credits, and court approval after public comment. The Chambers Works trial had been scheduled to begin May 19, 2025, so the settlement also removes near-term trial risk.
02—Key points
Key Highlights
- Proposed Judicial Consent Order with New Jersey resolves legacy Chambers Works PFAS claims and extends to statewide PFAS claims, including future claims, against 3M, subject to court approval and public comment.
- Pre-tax charge of approximately $285 million expected in Q2 2025: about $210 million for Chambers Works and other settlement elements, and about $75 million for statewide PFAS claims.
- Charge to be excluded from non-GAAP results, so GAAP earnings absorb the full impact while adjusted earnings do not.
- Total Settlement Payments of $400 million to $450 million, paid over roughly 24 years, subject to credits and adjustments tied to the public water supplier class settlement.
- New Jersey Leadership Payment of $50 million to $100 million is included, with credits that can reduce 3M's obligations for certain future Credit-Eligible Claims.
- Settlement carries no admission of liability or waiver of defenses, and removes the risk of the Chambers Works trial scheduled to begin May 19, 2025.
- Reinforces 3M's stated plan to exit all PFAS manufacturing and discontinue PFAS use across its portfolio by the end of 2025.
03—Questions
Frequently Asked Questions
How much will this settlement cost 3M and when will it be recorded?
3M expects a pre-tax charge of approximately $285 million in the second quarter of 2025, consisting of about $210 million for the Chambers Works resolution and other settlement elements and about $75 million for statewide PFAS claims. Total Settlement Payments under the Judicial Consent Order are between $400 million and $450 million, paid over time.
Will the settlement affect 3M's adjusted or GAAP earnings?
3M intends to treat the $285 million charge as an adjustment in arriving at non-GAAP results, so adjusted earnings will exclude it. The charge will still be recognized in GAAP results for the second quarter of 2025.
When are the payments due and what could change the amount?
Payments are scheduled over about 24 years, with the first payment of $100 million due within 30 days after the effective date. The final amounts depend partly on 3M's obligations under the 2023 public water supplier class settlement, and 3M may receive credits tied to other contingencies, including certain judgments or settlements involving non-released parties.
Is the settlement final and does 3M admit liability?
No. The settlement is subject to a public notice and comment period and court approval, and it includes no admission of liability or wrongdoing by 3M. If approval is not obtained or certain terms are not met, 3M has said it is prepared to continue defending itself in litigation.
What does the settlement mean for 3M's future PFAS exposure in New Jersey?
The settlement releases 3M from many statewide PFAS claims, including future claims the State may have, with specified exceptions such as ongoing remediation at certain former 3M sites. Because 3M is exiting PFAS manufacturing by the end of 2025, the State has acknowledged that newly manufactured PFAS entering New Jersey after 2025 will come from other sources, which limits 3M's forward exposure, though legacy and carve-out obligations remain.
04—Continue